NDRG1 Signaling Is Essential for Endothelial Inflammation and Vascular Remodeling

被引:28
|
作者
Zhang, Guanxin [1 ,2 ]
Qin, Qing [1 ]
Zhang, Chen [1 ]
Sun, Xiaobo [1 ]
Kazama, Kyosuke [1 ]
Yi, Bing [1 ]
Cheng, Fang [1 ]
Guo, Zhi-Fu [1 ,3 ]
Sun, Jianxin [1 ]
机构
[1] Thomas Jefferson Univ, Ctr Translat Med, 1020 Locust St,Room 368G, Philadelphia, PA 19107 USA
[2] Naval Med Univ, Changhai Hosp, Inst Cardiothorac Surg, Shanghai, Peoples R China
[3] Thomas Jefferson Univ, Ctr Translat Med, 1020 Locust St,Room 381, Philadelphia, PA 19107 USA
关键词
AP-1; Nur77; endothelial cells; inflammation; NDRG1; NF-kappa B; NF-KAPPA-B; VON-WILLEBRAND-FACTOR; NUCLEAR RECEPTOR NUR77; MOUSE CAROTID-ARTERY; THROMBOMODULIN EXPRESSION; METASTASIS SUPPRESSOR; GENE; ACTIVATION; CELLS; ATHEROSCLEROSIS;
D O I
10.1161/CIRCRESAHA.122.321837
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND: NDRG-1 (N-myc downstream-regulated gene 1) is a member of NDRG family that plays essential roles in cell differentiation, proliferation, and stress responses. Although the expression of NDRG1 is regulated by fluid shear stress, its roles in vascular biology remain poorly understood. The purpose of the study is to determine the functional significance of NDRG1 in vascular inflammation and remodeling. METHODS AND RESULTS: By using quantitative polymerase chain reaction, western blot, and immunohistochemistry,we demonstrate that the expression of NDRG1 is markedly increased in cytokine-stimulated endothelial cells and in human and mouse atherosclerotic lesions. To determine the role of NDRG1 in endothelial activation, we performed loss-of-function studies using NDRG1 short hairpin RNA. Our results demonstrate that NDRG1 knockdown by lentivirus bearing NDRG1 short hairpin RNA substantially attenuates both IL-1 beta (interleukin-1 beta) and TNF-alpha (tumor necrosis factor-alpha)-induced expression of cytokines/chemokines and adhesion molecules. Intriguingly, inhibition of NDRG1 also significantly attenuates the expression of procoagulant molecules, such as PAI-1 (plasminogen activator inhibitor type 1) and TF (tissue factor), and increases the expression of TM (thrombomodulin) and t-PA (tissue-type plasminogen activator), thus exerting potent antithrombotic effects in endothelial cells. Mechanistically, we showed that NDRG1 interacts with orphan Nur77 (nuclear receptor) and functionally inhibits the transcriptional activity of Nur77 and NF-kappa B (nuclear factor Kappa B) in endothelial cells. Moreover, in NDRG1 knockdown cells, both cytokine-induced mitogen-activated protein kinase activation, c-Jun phosphorylation, and AP-1 (activator protein 1) transcriptional activity are substantially inhibited. Neointima and atherosclerosis formation induced by carotid artery ligation and arterial thrombosis were markedly attenuated in endothelial cell-specific NDRG1 knockout mice compared with their wild-type littermates.CONCLUSIONS: Our results for the first time identify NDRG1 as a critical mediator implicated in regulating endothelial inflammation, thrombotic responses, and vascular remodeling, and suggest that inhibition of NDRG1 may represent a novel therapeutic strategy for inflammatory vascular diseases, such as atherothrombosis and restenosis.
引用
收藏
页码:306 / 319
页数:14
相关论文
共 50 条
  • [21] Ndrg1 in development and maintenance of the myelin sheath
    King, Rosalind H. M.
    Chandler, David
    Lopaticki, Sash
    Huang, Dexing
    Blake, Julian
    Muddle, John R.
    Kilpatrick, Trevor
    Nourallah, Michelle
    Miyata, Toshiyuki
    Okuda, Tomohiko
    Carter, Kim W.
    Hunter, Michael
    Angelicheva, Dora
    Morahan, Grant
    Kalaydjieva, Luba
    NEUROBIOLOGY OF DISEASE, 2011, 42 (03) : 368 - 380
  • [22] A review on the role of NDRG1 in different cancers
    Soudeh Ghafouri-Fard
    Sara Ahmadi Teshnizi
    Bashdar Mahmud Hussen
    Mohammad Taheri
    Guive Sharifi
    Molecular Biology Reports, 2023, 50 : 6251 - 6264
  • [23] NDRG1 in Cancer: A Suppressor, Promoter, or Both?
    Joshi, Vaibhavi
    Lakhani, Sunil R.
    Reed, Amy E. McCart E.
    CANCERS, 2022, 14 (23)
  • [24] ENDOTHELIAL MTOR SIGNALING DRIVES VASCULAR INFLAMMATION
    Stothers, Cody L.
    Guo, Yin
    Travisano, Katherine
    Luan, LiMing
    Bohannon, Julia K.
    Montano, Marian
    Williams, David L.
    Sherwood, Edward R.
    SHOCK, 2018, 49 (06): : 81 - 82
  • [25] Mapping and expression analysis of chicken NDRG1 and NDRG3 genes
    Tian, Yong
    Xu, Minlin
    Fu, Yan
    Yuan, Aiping
    Wang, Deqian
    Li, Guoqin
    Liu, Gentao
    Lu, Lizhi
    BIOCHEMICAL GENETICS, 2008, 46 (9-10) : 677 - 684
  • [26] Mapping and Expression Analysis of Chicken NDRG1 and NDRG3 Genes
    Yong Tian
    Minlin Xu
    Yan Fu
    Aiping Yuan
    Deqian Wang
    Guoqin Li
    Gentao Liu
    Lizhi Lu
    Biochemical Genetics, 2008, 46 : 677 - 684
  • [27] MLL5α activates AR/NDRG1 signaling to suppress prostate cancer progression
    Quan, Yongjun
    Cui, Yun
    Wahafu, Wasilijiang
    Liu, Yuexin
    Ping, Hao
    Zhang, Xiaodong
    AMERICAN JOURNAL OF CANCER RESEARCH, 2020, 10 (05): : 1608 - +
  • [28] Dual functions of NDRG1 in cell growth and invasion
    Li, Hsiao-Fang
    Cheng, Ann-Joy
    CANCER RESEARCH, 2011, 71
  • [29] ENDOTHELIAL DYSFUNCTION AND VASCULAR REMODELING IN PATIENTS WITH ESSENTIAL ARTERIAL HYPERTENSION
    Danilogorskaya, Y.
    Belenkov, Y. U.
    Privalova, E.
    Zheleznykh, E.
    Shakaryants, G.
    Kozhevnikova, M.
    Schendrygina, A.
    Lishuta, A.
    JOURNAL OF HYPERTENSION, 2017, 35 : E251 - E251
  • [30] Metastasis suppressor, NDRG1, mediates its activity through signaling pathways and molecular motors
    Sun, Jing
    Zhang, Daohai
    Bae, Dong-Hun
    Sahni, Sumit
    Jansson, Patric
    Zheng, Ying
    Zhao, Qian
    Yue, Fei
    Zheng, Minhua
    Kovacevic, Zaklina
    Richardson, Des R.
    CARCINOGENESIS, 2013, 34 (09) : 1943 - 1954